[Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate]

Urologe A. 1997 Nov;36(6):568.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Randomized Controlled Trial

MeSH terms

  • Analgesics, Non-Narcotic / therapeutic use*
  • Antibiotics, Antineoplastic / therapeutic use*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / physiopathology*
  • Bone Neoplasms / secondary*
  • Clodronic Acid / therapeutic use*
  • Drug Resistance, Neoplasm
  • Epirubicin / therapeutic use*
  • Humans
  • Male
  • Pain / drug therapy*
  • Prospective Studies
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / physiopathology

Substances

  • Analgesics, Non-Narcotic
  • Antibiotics, Antineoplastic
  • Clodronic Acid
  • Epirubicin